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ABSTRACT
This study determined the biotypes of group A
streptococci (GAS) isolated from 66 pharyngeal
and 62 skin and soft-tissue infections. Among all
GAS isolates tested, the most common biotypes
were 1 and 3, irrespective of the isolation source
and the severity of clinical symptoms. However,
compared with the pharyngeal group, a more
heterogeneous distribution of biotypes was ob-
served among the cutaneous group of isolates,
including seven isolates that were non-typeable
but had an identical biotype pattern, suggesting
that they may represent a new biotype.
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Streptococcus pyogenes (group A streptococci; GAS)
causes a variety of infectious diseases in humans,
which vary greatly in terms of severity. In order
to recognise and control GAS infections, it is
important to understand the epidemiology of
GAS disease, as well as the linkage between the
virulence of this pathogen and its epidemiological
markers. Most epidemiological studies classify
S. pyogenes by M serotypes and ⁄ or emm types [1].
In addition, a simple and reliable biotyping
system has been described that recognises ten
biotypes of S. pyogenes, based on variations in
biochemical characteristics [2]. The few studies
performed to date suggest that the distribution of
GAS biotypes might vary according to the asso-
ciated diseases and the geographical region
involved [3,4].
The present study is a preliminary report on the
GAS biotypes of isolates obtained at 14 microbio-
logical laboratories in Serbia from patients with
pharyngitis or skin and soft-tissue (SST) infections
between March 2001 and April 2002. During that
period, all isolates from hospitalised patients with
SST infection (n = 62) were included in the study,
while pharyngitis isolates (n = 66) were obtained
from outpatients selected randomly.
Pharyngeal isolates of GAS were grown from
throat swabs of patients with clinical signs of
acute pharyngitis, whereas SST isolates were
grown from wound swabs and tissue of patients
who suffered from wound infections and celluli-
tis. The isolates were identiﬁed by conventional
methods [5] and biotyping was performed using
the Rapid ID 32 STREP system (bioMe´rieux,
Marcy l’Etoile, France), according to the recom-
mendations of the manufacturer. S. pyogenes iso-
lates were biotyped according to their ability to
ferment mannitol, cyclodextrin, glycogen, methyl-
b-D-glucopyranoside and pullulan, and their
ability to produce b-glucuronidase, as described
previously [2]. Sequence analysis of emm genes
was performed according to the method
described by the CDC (http://www.cdc.gov/nci
dod/biotech/strep/protocols.htlm). Compari-
sons between the pharyngitis and SST infection
groups were made using chi-square tests, with
p values <0.01 being considered signiﬁcant.
The study revealed the presence of seven GAS
biotypes (1, 2, 3, 4, 5, 6 and 8). All biotypes were
represented among isolates from both pharyngitis
and SST infections, with the exception of biotype
2, which was found only in the pharyngitis group.
Biotypes 7, 9 and 10 were not represented among
any of the clinical isolates studied. The most
prevalent biotypes among both groups of patients
were biotypes 1 and 3, although with opposing
distributions, with biotype 1 being more common
among the SST group (37%) and biotype 3 being
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more common among the pharyngitis group
(56%) (Table 1). In total, almost 85% of pharyn-
geal isolates and 70% of SST isolates belonged to
these two biotypes. Biotype 3 was signiﬁcantly
more frequent among GAS isolates associated
with pharyngitis (56%) than among SST isolates
(32%). Other biotypes were encountered less
frequently in both groups (Table 1). No correla-
tion was observed between the presence of a
particular biotype and the severity of the disease
(data not shown).
The biotype distribution of pharyngeal S. pyo-
genes isolates from these patients was similar to
that reported among French patients with phar-
yngitis [6]. However, a second study from the
same group, of a much wider spectrum of
diseases, revealed a predominance of biotype 1
in France [3]. In contrast, a study in India found
that biotype 10 was the predominant biotype
among GAS isolates causing pharyngitis and
pyoderma [4]. Taken together, the present data
provide further support for the concept of a
diverse distribution of GAS biotypes in different
geographical regions.
In the present study, seven (11%) of 62 cuta-
neous isolates were non-typeable, i.e., they could
not be classiﬁed into any of the ten established
biotypes based on the standard reactions.
Interestingly, all seven isolates had an identical
biotype pattern, characterised by the production
of b-glucuronidase and an ability to acidify all
ﬁve carbohydrates. Identiﬁcation at the pheno-
typic level, based on agglutination reactions and
Rapid ID 32 STREP results, clearly conﬁrmed that
these isolates were S. pyogenes. Since they origin-
ated from patients treated in several hospitals in
different regions in Serbia, the possibility of
epidemic bias resulting from the isolation of the
same strain was low. Based on these ﬁndings, it is
possible that these isolates might represent a new
biotype (biotype 11) that has not been reported
previously (Table 2). Sequence analysis of the
emm genes in these isolates revealed three distinct
emm types: 82 (four isolates), 117 (two isolates)
and 53 (one isolate). Previous studies have asso-
ciated speciﬁc M ⁄ emm types with particular
biotypes [2,6–8]. Interestingly, the emm types
identiﬁed for these seven isolates have not been
associated with any of the previously deﬁned
biotypes, which provides further support for the
hypothesis that a new biotype (biotype 11) has
emerged.
In conclusion, biotypes 1 and 3 were revealed
to be the GAS biotypes isolated most frequently
from all specimens, irrespective of the severity of
the clinical symptoms. Furthermore, no associ-
ation between speciﬁc GAS biotypes and partic-
ular clinical diseases was observed. The possible
identiﬁcation of a new biotype among isolates
from SST infections merits further large-scale
investigation. Taken together, the results give a
new insight into the clinical and geographical
distribution of GAS biotypes that may help to
establish the utility of GAS biotyping as a rapid
and simple epidemiological tool that can be used
in advance of emm gene sequencing, which
remains the ultimate reference standard for GAS
typing.
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ABSTRACT
This study evaluated the application of the French
guidelines for prevention of neonatal group B
streptococcus (GBS) infections. The prevalence of
GBS vaginal carriage by pregnant women during
the study period was 6%. Less than 50% of
pregnant women testing positive for GBS were
treated with at least two doses of antibiotics
during labour, and most received only one dose
or no antibiotics. In addition, several neonates
were colonised or infected by GBS although their
mothers were GBS-negative. These results are
consistent with vaginal screening having a poor
sensitivity, as suggested by the low prevalence of
GBS carriage.
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Various guidelines have been published in
developed countries for reducing group B strep-
tococcus (GBS) neonatal infections, especially
early-onset disease [1–5]. In France, guidelines
for reducing the neonatal risk of early bacterial
infections were published in September 2001 [6],
and these recommend vaginal screening between
weeks 34 and 38 of pregnancy to allow intra-
partum antibiotic prophylaxis to be given, if
needed, to GBS carriers during labour [6]. Rectal
screening is not recommended; neither is selective
enrichment in liquid medium or on a speciﬁc agar
medium. Systemic antibiotic prophylaxis is ap-
propriate if neonatal GBS infection had occurred
during a previous pregnancy, if GBS bacteriuria
occurred during the current pregnancy, or if GBS
carriage was detected at any time during the
current pregnancy. Antibiotic prophylaxis is also
recommended if no vaginal sample is available
for GBS screening and one of the following risk-
factors is present: labour before 37 weeks of
pregnancy; membranes ruptured for >12 h; or
maternal temperature >38C during labour [6].
The present prospective study evaluated the
application of GBS screening in the maternity unit
of the Tours University Hospital, France, which
delivers 3800 babies annually. The results of all
vaginal GBS screens of pregnant women were
collected between March 2004 and September
2004, together with the results of gastric ﬂuid and
placental cultures for the corresponding neonates.
When positive results for GBS were obtained,
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